Shaping the future of European health research: policy recommendations of the Biomedical Alliance in Europe for Framework Programme 10 and beyond

IF 3.5 4区生物学 Q1 Biochemistry, Genetics and Molecular Biology

FEBS Letters Pub Date : 2025-05-27 DOI:10.1002/1873-3468.70079

Wilfried Ellmeier, Marieke Meijer, Miriam Madrignani, Loredana Simulescu, Tom Hemming Karlsen, Elizabeth Macintyre, the members of the BioMed Alliance Health Research Committee

{"title":"Shaping the future of European health research: policy recommendations of the Biomedical Alliance in Europe for Framework Programme 10 and beyond","authors":"Wilfried Ellmeier, Marieke Meijer, Miriam Madrignani, Loredana Simulescu, Tom Hemming Karlsen, Elizabeth Macintyre, the members of the BioMed Alliance Health Research Committee","doi":"10.1002/1873-3468.70079","DOIUrl":null,"url":null,"abstract":"<p>As Europe charts its course for the next funding programme for research, Framework Programme 10 (FP10), the stakes have never been higher. In order to increase European competitiveness in research and innovation and generate better outcomes for patients, the Biomedical Alliance in Europe urges policymakers to embrace health and biomedical research as a strategic investment. We call for strong funding to support the translational health research value and innovation chain. We advocate for reducing the administrative burden in grant applications, and for simplification and harmonization of the regulatory framework. In addition, we call for strengthening of strategic leadership, coordination, collaboration and training. FP10 promises to transform European health research into a driver of societal well-being, economic growth and global leadership.</p>","PeriodicalId":12142,"journal":{"name":"FEBS Letters","volume":"599 12","pages":"1625-1633"},"PeriodicalIF":3.5000,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/1873-3468.70079","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FEBS Letters","FirstCategoryId":"99","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/1873-3468.70079","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}

引用次数: 0

Abstract

As Europe charts its course for the next funding programme for research, Framework Programme 10 (FP10), the stakes have never been higher. In order to increase European competitiveness in research and innovation and generate better outcomes for patients, the Biomedical Alliance in Europe urges policymakers to embrace health and biomedical research as a strategic investment. We call for strong funding to support the translational health research value and innovation chain. We advocate for reducing the administrative burden in grant applications, and for simplification and harmonization of the regulatory framework. In addition, we call for strengthening of strategic leadership, coordination, collaboration and training. FP10 promises to transform European health research into a driver of societal well-being, economic growth and global leadership.

Abstract Image

查看原文本刊更多论文

塑造欧洲卫生研究的未来：欧洲生物医学联盟为框架方案10及其以后提出的政策建议。

随着欧洲为下一个研究资助计划框架计划10 （FP10）制定路线，风险从未如此之高。为了提高欧洲在研究和创新方面的竞争力并为患者带来更好的结果，欧洲生物医学联盟敦促决策者将卫生和生物医学研究作为一项战略投资。我们呼吁为转化卫生研究价值链和创新链提供强有力的资金支持。我们主张减少拨款申请的行政负担，并简化和协调监管框架。此外，我们呼吁加强战略领导、协调、合作和培训。FP10承诺将欧洲的卫生研究转变为社会福祉、经济增长和全球领导地位的驱动力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

FEBS Letters 生物-生化与分子生物学

CiteScore

7.00

自引率

2.90%

发文量

303

审稿时长

1.0 months

期刊介绍： FEBS Letters is one of the world''s leading journals in molecular biology and is renowned both for its quality of content and speed of production. Bringing together the most important developments in the molecular biosciences, FEBS Letters provides an international forum for Minireviews, Research Letters and Hypotheses that merit urgent publication.